Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

DEXCOM, INC. (DXCM)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 01/16 04:00:00 pm
147.05 USD   --.--%
2013DEXCOM, INC. : quaterly earnings release
2012DEXCOM, INC. : quaterly earnings release
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/10/2019 01/11/2019 01/14/2019 01/15/2019 01/16/2019 Date
141.9(c) 141.1(c) 142.74(c) 147.05(c) 147.05(c) Last
2 608 655 880 605 1 242 153 1 388 734 989 434 Volume
+2.27% -0.56% +1.16% +3.02% 0.00% Change
More quotes
Financials (USD)
Sales 2018 987 M
EBIT 2018 -6,73 M
Net income 2018 49,1 M
Finance 2018 236 M
Yield 2018 -
Sales 2019 1 190 M
EBIT 2019 36,3 M
Net income 2019 16,7 M
Finance 2019 357 M
Yield 2019 -
P/E ratio 2018 261,93
P/E ratio 2019 781,35
EV / Sales2018 13,0x
EV / Sales2019 10,7x
Capitalization 13 065 M
More Financials
Company
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
01/07DEXCOM INC : Results of Operations and Financial Condition, Financial Statements..
AQ
01/07DEXCOM : Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter an..
BU
2018DEXCOM INC : Entry into a Material Definitive Agreement, Creation of a Direct Fi..
AQ
2018DEXCOM : Announces Upcoming Conference Presentation
BU
2018DEXCOM INC : Entry into a Material Definitive Agreement, Creation of a Direct Fi..
AQ
2018Smart Medical Devices Market to cross USD 66 billion by 2024 | Primary key pl..
AQ
2018DEXCOM INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2018DEXCOM : Prices Offering of $750.0 Million of 0.75% Convertible Senior Notes
BU
2018DEXCOM INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2018DEXCOM : Announces Proposed Offering of $750 Million of Convertible Senior Notes
BU
More news
Analyst Recommendations on DEXCOM, INC.
More recommendations
Sector news : Medical Equipment, Supplies & Distribution - NEC
01/16PG&E to get pulled out of S&P 500, shares near 2001 lows
RE
01/16ABBOTT LABORATORIES : Exercises Option to Buy Cephea Valve Technologies
DJ
01/14ABBOTT LABORATORIES : Labs Gets FDA Approval for Amplatzer Piccolo Occluder
DJ
01/10Hearing aid makers Widex and Sivantos reopen EU merger application
RE
01/07Medtronic Closes Down 6.45%, Largest Percent Decrease Since November 2016 -- ..
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 149 $
Spread / Average Target 1,4%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer Chairman, President & Chief Executive Officer
Jeffrey C. Moy Senior Vice President-Operations
Quentin Blackford Chief Financial Officer
Jacob Leach Senior Vice President-Research & Development
Jay S. Skyler Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.22.75%13 065
MEDTRONIC PLC-4.36%113 823
BAXTER INTERNATIONAL3.71%35 185
HOYA CORPORATION-1.05%22 540
TERUMO CORP0.86%21 104
ZIMMER BIOMET HOLDINGS1.23%20 946